Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mannin Research

Mannin Research
2012 FOUNDED
M&A STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$5.7M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of a medical technology intended to help treat glaucoma and cystic kidney diseases. The company's therapeutics use the Tie2 mechanism to address a number of vascular disease indications to treat vascular-related diseases, such as Primary Open Angle Glaucoma, Pediatric Glaucoma, Cystic Kidney Disease and Inflammation, enabling medical professionals to treat patients with a spectrum of vascular diseases.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Q BioMed
Primary Office
  • 629 Eastern Avenue
  • Suite C300
  • Toronto, Ontario M4M 1E4
  • Canada

+1 (416) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mannin Research’s full profile, request a free trial.

Mannin Research Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 05-Nov-2019 $5.7M Completed Pre-Clinical Trials
3. Accelerator/Incubator 02-Feb-2017 Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Pre-Clinical Trials
1. Merger/Acquisition 13-Jan-2016 Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

Mannin Research Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Matter Accelerator/Incubator 000 0000 000000 0

Mannin Research Executive Team (4)

Name Title Board
Seat
Contact
Info
George Nikopoulos Ph.D Chief Executive Officer and President
Susan Quaggin Chief Scientific Officer & Board Member
Doris Qamar Executive
Geoffrey Smith Secretary of the Board of Directors

Mannin Research Board Members (3)

Name Representing Role Since Contact
Info
Christopher Smith Self Chairman 000 0000
Geoffrey Smith Mannin Research Secretary of the Board of Directors 000 0000
Susan Quaggin Mannin Research Chief Scientific Officer & Board Member 000 0000